Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]
Guo A +10 more
europepmc +1 more source
Slow progress in measles and rubella elimination in Italy [PDF]
Adamo, Giovanna +4 more
core +2 more sources
Buschke-Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine. [PDF]
Deshmukh A +3 more
europepmc +1 more source
Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study. [PDF]
Pula JR +10 more
europepmc +1 more source
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial. [PDF]
Baker B +6 more
europepmc +1 more source
Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc +1 more source
Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]
Otiv M, Botre A, Shah P.
europepmc +1 more source
A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland [PDF]
Bielecki +42 more
core +1 more source
High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. [PDF]
Prosperi C +26 more
europepmc +1 more source

